Happy New Year to CDEX Shareholders!

MERRY CHRISTMAS TO CDEX SHAREHOLDERS....

Ebay Fire Sale!

One well used cdex hack employee....best offer?

CDEX 8K....

http://www.streetinsider.com/SEC+Filings/Form+8-K+CDEX+INC+For%3A+Oct+16/10981864.html

Link to CDEX: http://cdex-inc.com/

CDEX's John Coates, Ph.D., Csci, CChem, FRSC - Sentelligence Chief Technology Officer is a globally recognized expert in optical spectroscopy.






Dr. Coates is also an advisor to US Dept of Energy




Sentelligence was founded in July of 2000 with the mission of developing a proprietary sensor platform technology at a low market price.



http://www.zoominfo.com/p/John-Coates/88569941

CDEX's Capital Markets Advisor is Hanover International.






http://cdex-inc.com/investors/ceo-corner/




Due to the established growing needs for our technology and given the fact that we are very close to commercialization and implementation of our ValiMed G4, CDEX has engaged Hanover International as its Capital Markets Advisor. Hanover International will maintain a proactive investor relations outreach effort, keep an open line of communication with the investment community and help guide us as we build our investment banking relationships, which could prove to be pivotal in our quest to accomplish our business plan and our near term growth strategies.




http://www.hanoverintlinc.com/jimhock/




James E. Hock, President and CEO





James Hock




http://www.hanoverintlinc.com/services/





Capital Formation and Financing Strategies


Strategic Market Awareness and Development


Corporate Finance Advisory


Shareholder/Investor Relations


Regulatory Compliance


Market Research


New Business Development


Creative/Collateral Materials




http://www.hanoverintlinc.com/our-team/








Advisory Team

Kathy Addison

With over 8 years’ experience in public and investor relations, Kathy brings Hanover International honed leadership and proven business skill as an accomplished logistical taskmaster and workflow processes innovator. Kathy is responsible for managing and guiding all operational and logistical details and strategies related to Hanover’s clients’ respective campaign initiatives; while also providing the leadership, management and vision necessary to ensure that Hanover and its many clients adhered to best industry practices and compliant administrative and reporting activities. More specifically, I oversee all aspects of Hanover’s administrative operations, which include provision of client services that ranged from shareholder and investor relations; public relations; financial roadshow planning, booking and implementation; preparation and processing of press releases; design and development of required collateral materials; and assisting with SEC compliance and reporting, among other essential duties. I also lend event planning and implementation support to the National Investment Banking Association, which hosts four large conferences in major U.S. financial centers each year.

Gary Augusta

Gary brings over 20 years’ experience to his current roles, with experience as a CEO, CFO, growth capital, M&A and corporate development, venture/micro private equity investing, operations consulting and business strategy for small to Fortune 500 companies.

As Executive Chairman of Apollo Medical Holdings (OTC: AMEH) and Board Director of ApolloMed Accountable Care Organization (ACO), Gary provides strategic direction, leadership, capital markets and corporate partnership development, IT strategy and M&A expertise. Apollo Medical is a physician driven integrated healthcare company providing physician and hospitalist care for inpatients as well as full medical management of IPAs, ACOs, Clinics and Palliative Care.

As President and CEO of OCTANe, Gary created and led a million dollar Innovation Development Company (IDC) that helped create, grow, support, staff and fund innovative growth companies. OCTANe has helped 50+ companies raise $75+MM and created a $30MM regional venture capital fund focused on biomedical, technology, healthcare services, diagnostics and other technical industries.

Lynne Bolduc

Over the past two decades, FitzGerald, Yap & Kreditor Partner, Lynne Bolduc, has established herself as one of the premier corporate and securities lawyers in California. She has structured and implemented over $1 billion in financings, and has represented both domestic and international clients in complex transactions across multiple industries. She represents both private and public companies, as well as investment bankers and broker/dealers. Lynne’s experience includes: entity selection and formation matters for businesses just getting started; contract negotiations; review, and drafting, mergers and acquisitions; private offerings; public offerings; and public company reporting with the Securities and Exchange Commission. Lynne is a member of the Board of Directors for the National Investment Banking Association, a not-for-profit association for national, regional and independent broker dealers, investment banking firms, investment advisors, and related capital market service providers.

Art Brent

Art Brent is the founder and president of StockVest, a 12 year well respected market relations firm that has established a strong presence in the investment community. Stockvest works closely with a substantial network of partners, market professionals and event organizers to effectively communicate positive and compelling reasons for investment consideration gaining rapid exposure of a company, by way of a newsletter. The StockVest Newsletter has a wide audience of reader, now over 120,000, as well as bonus distribution at many national and international events each year.

The StockVest database is well maintained and collected over the years from both direct signups on websites and from investment events. StockVest works closely with and sponsor many large investment related events each year including the Marcum Microcap Conference, Rodman and Renshaw, The National Investment Banking Association, See Thru Equity, One Med Place, Cambridge House, The Money Show, and The New Orleans Investment Conference to name a few.

The StockVest Market Awareness Program is specifically designed and focused on helping companies expand their shareholder base, increase their share valuations and trading volumes.

Andrea Cataneo

Andrea Cataneo is a long term partner with Sichenzia Ross Friedman Ference LLP (“SRFF”), which provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. Her practice focuses on structuring secured and unsecured private equity financing transactions for microcap companies, and taking companies public. Additionally, through her extensive relationships in the investment banking community, Andrea offers her clients targeted sources of capital and merger and acquisition opportunities. She represents companies with their reporting obligations to the SEC, as well as with exchange listing and FINRA compliance matters. Her practice covers domestic and international transactions, and she has been active in Argentina, Canada, China, India, Israel, Kenya and Russia. Andrea was named “Woman of the Year” for two consecutive years by the National Association of Professional Women, and she presently serves on the Board of the National Investment Banking Association (NIBA).

Brian Cavalli

Brian is the New Business Director for Vintage, a division of PR Newswire. Trusted for over 60 years, PR Newswire is the world’s largest network for distributing news; offering the most ways for a company to reach audiences online and off with more than 200,000 media and 10,000 Websites points of distribution.

Vintage, is a top-three provider of full-service regulatory compliance and shareholder communications services. Vintage has evolved to become the industry’s intelligent value choice. The Company’s services include IPO registrations, transactions, virtual data rooms, EDGAR & XBRL filing, typesetting, financial printing and investor relations websites.

Seth Farbman

Seth Farbman has built a career in servicing private and public companies. He was the co-founder and is President of Vintage Filings, which he sold to PR Newswire in 2007. In this role, Seth services over 3,000 publicly traded companies to provide SEC EDGAR and financial print services related to IPOs, Proxy Statements, Annual Reports, Shareholder Meetings and all aspects of compliance filings. He is also Co-Chairman of Vcorp Services, a New York based state filing firm which works with individuals and lawyers in entity formations, business filings, not-for-profit applications, compliance services and more. Prior to starting Vintage Filings, Seth served as a securities attorney at a New York law firm with a concentration on securities regulation. He is a licensed attorney in New York and New Jersey and has been a member of the American Bar Association and of the ABA’s Committee on the Federal Regulation of Securities. Seth also serves as Co-Chairman of Vcheck Global, a California based, and corporate background check company.

Michael Gibstine

Michael has spent over 30 years in the automotive industry as a sales engineer and program manager. His work experience includes the handling all aspects of product development, including manufacturing, sale negotiations and product delivery for new technologies to both the American and Japanese suppliers.

In addition to the auto industry, Michael has worked with component suppliers to sell their products. By setting up manufacturer representative territories through negotiated contracts, training and sales calls, Michael was able to reach and sell to appliance, medical, contract manufacturers and startups nationally.

Jerry Lindberg

Jerry Lindberg has acquired substantial expertise as a consultant, adviser and former litigating attorney with the United States Department of Justice and in the private sector. He has served as board member and CFO of publicly traded companies, business adviser and consultant, capital acquisition director, and operations officer to real world and Internet start-ups and helped raise capital for start-ups, small and microcap businesses in both the public and private sectors. His experience includes business plan preparation, early stage advising for corporate development and positioning for capital raising including crowd funding, private placement memoranda, investor presentation development, equity, debt and hybrid funding, form preparation and filing, offering syndicate coordination, sales/ marketing strategy along with investment community relations and investor relations, business development, licensing management, and assuring compliance with Federal and state regulations and fraud prevention software development. His areas of specialty include technology and intellectual property management, digital entertainment, media and marketing, eCommerce, m-Commerce, software design and development.

Don McDonald

Don has over 30 years of capital markets experience on Wall Street. Don is the Founder and CEO of Consilium Global Research and with its staff of a dozen senior Wall Street analysts, the Company provides research coverage and advisory services to public and private companies. Don’s experience includes: Managing Director at Shearson Lehman, Managing Director at Raymond James for 15 years and Managing Director, Head of Institutional Sales at Jesup & Lamont and CK Cooper.

Robert K Gardner

Robert K. Gardner is the founding partner of New World Technology Partners (NWTP) – a collaboration of engineering, financial and government leaders incubating strategic technologies and ventures at the intersection of business and public policy.

He has been a leader in cyber and critical infrastructure risk management technology and an incubator of entrepreneurial enterprises since the seventies. He managed/participated in the launch of several development stage companies, including August Systems, Verdix, Meiko Scientific, Cryptek, Phoenix Numeric, Probity Labs and Location-Sentry.

Prior to forming NWTP, he held senior engineering and technical marketing positions for ILLIAC IV, PEPE, LDSP and NASF supercomputer projects at Burroughs Corporation.

He writes, speaks and has prepared testimony for the U.S. House of Representatives and Senate caucuses on the Enterprise impact of cyber risk.

Gardner has a BSEE from Rensselaer Polytechnic Institute and studied graduate system engineering and business administration at Penn State and the University of Santa Clara respectively.

Stasi Turrell

Stasi is a communications expert having crafted comprehensive, highly polished communications platforms that have aided in raising growth capital and market awareness for private, pre-public and publicly traded clients in a variety of industries. Stasi began her career with Ernst & Young in the technology consulting services division, after which she helped launched a technology start-up, which grew into a multi-million dollar technology services company. She later managed Corporate Communications for a Dallas-based international technology services company with operations in China, Latin America and North America.

She has worked in conjunction with Deloitte, Ernst & Young, the Dallas / Ft. Worth Metroplex Technology Business Council and the Dallas Chamber of Commerce on various awards and recognition programs. She has also consulted internationally with The Academy of Educational Development, a group funded by USAID, and a private sector task force with the United Nation’s ISDR program focused on reducing disaster risk in communities worldwide through public-private partnerships. Stasi holds both a BS in Electrical Engineering and a BA in Plan II Liberal Arts from the University of Texas in Austin.











Contact


Corporate Headquarters
Hanover International, Inc.
40 Wall Street
New York, NY 10004

760-564-7400

Partner Links

Consilium Global Research
FitzGerald Yap Kreditor LLP
National Investment Banking Association (NIBA)
New World Technology Partners
Sichenzia Ross Friedman Ference LLP
StockVest
The Vintage Group
Transfac Capital
VStock Transfer

CDEX's J Coates, PhD 2014 hey, CDEX's ValiMed G4s have lasers. hmmm Found in the leading review journal for business and technology in the pharmaceutical industry throughout North America

Many enabling technologies can be cited, but for the construction of a replacement to the traditional spectrometer, the following have been the most relevant: thin film filter technologies, MEMS (as applied to spectroscopy, such as new detectors, spatial modulators and solid state thermal emitters), Lasers, LEDs and alternative light sources, fiber optic assemblies, and high performance detector arrays. Note that that the use of these newer technologies does not exclude existing technologies that are implemented within commercially available instruments.

..

Lasers and LEDs are a natural fit, size-wise, as efficient sources for microspectrometer systems. A wide range of tunable laser diodes (TDLs) are now available, primarily in the near-infrared spectral region, and broadly tunable mid-infrared lasers are available in the form of quantum cascade lasers (QCLs). In the broadly tunable format, these lasers essentially function as a spectrometer, where tuning ranges can be as broad as 2-3 microns wide. LEDs, while not tunable, may be obtained over a broad range of wavelengths covering from the UV (250nm) to the NIR (1450nm) and more recently out to the upper mid-IR (around 3 microns). The devices at the extremes (UV and the mid-IR) are more specialized and are expensive. However, LEDs with wavelengths from 360nm to 1450nm are relatively inexpensive and readily available, and can be packaged in multi-wavelength (multi-die) formats.

..

American Pharmaceutical Review is the leading review journal for business and technology in the pharmaceutical industry throughout North America. Each issue offers American Pharmaceutical Review's 30,000 readers unbiased editorial coverage of the latest developments in: drug delivery, information technology, research & development, analytical development and control, equipment and facility manufacturing and regulatory affairs. With its in-depth coverage, American Pharmaceutical Review is able to keep its readership of senior executives, technical personnel, scientists, and others fully abreast of the latest trends and developments in the process of pharmaceutical manufacturing.




http://www.americanpharmaceuticalreview.com/Featured-Articles/163573-A-Review-of-New-Small-Scale-Technologies-for-Near-Infrared-Measurements/

http://www.americanpharmaceuticalreview.com/1501-About-Us/

CDEX Director Coates, Paradigm Shifts in Spectroscopic Measurements: Example…Spectral Sensors

University of Washington




http://depts.washington.edu/cpac/Activities/Meetings/Fall/2010/documents/NeSSI_Workshop_November_2010_Coates.pdf


Recipient of the 2013 Pittcon Awards, Dr John Coates




Biophotonics Next-Generation IR Microscopy: The Devil Is in the Detail



CDEX's John Coates, Coates Consulting




One of the most important attributes of infrared spectroscopy is its ability to handle physically small samples or small features on samples. Important applications include forensic analysis of a crime scene, where infinitesimal evidentiary samples are collected for identification and/or characterization. Another consideration is the ability to isolate and characterize cell defects, including the cancerous regions of a biological specimen. In the early days of IR spectroscopy, the issue was how to handle such small samples and how to get sufficient energy to them to enable recording a useful spectrum. The options ranged from using relatively low cost microsampling accessories, such as beam condensers, to specially configured microscope accessories. For more than a decade, the role of the IR microscope has been growing, and dedicated products are available that enable microscopic-scale samples to be handled and characterized on a routine basis. Although these products can be extremely expensive – ranging from approximately $40,000 to $200,000 – they are one of the most valuable and cost-effective tools in the analytical arsenal. More recently, the biggest advances have been in imaging areas, with either mapping stages or imaging arrays, or combinations of both.




http://www.americanlaboratory.com/Blog/133331-Pittcon-2013-Award-Winners/

http://www.photonics.com/Article.aspx?AID=44683

CDEX's patented technology (nbr 9,013,686) now under their new Technical Director for Spectroscopy Products, award winning John Coates, PhD




As disclosed above, system 100 identified and quantifies molecular and chemical compounds using Enhanced Photoemission Spectroscopy, or EPS. EPS utilizes at least three different kinds of light interactions with molecular structures. Preferably, the disclosed embodiments use three different light interactions, which correspond to modules 124-28. Additional modules may be added to system 100 for additional light interaction analysis implemented.

One type of interaction used in the disclosed processes is fluorescence. Fluorescence is the emission of light by a substance having electrons that absorb light at a different wavelength. It may be a form of luminescence. As used above, the emitted light is longer in wavelength than the incident light, and, therefore, also is lower in energy than the incident light. When the absorbed light is very intense, such as produced by a laser, it is possible for one electron to absorb two photons. This two photon absorption may lead to emission of radiation having a shorter wavelength than the incident radiation. Thus, errors may occur using only a fluorescence process to identify sample 110, since many molecule combinations produce a similar fluorescence spectrum.

Another type of light interaction is Raman interaction, disclosed above. If the incident light is scattered from molecules in the target of interest, such as sample 110, the majority of the incident photons are elastically scattered, also known as Rayleigh scattering. This scattering produces no shift in the wavelength compared to the incident photons. The minority of the incident photons, such as about 1 in 10.sup.7, are inelastically scattered by an excitation with the scattered photons having a wavelength different from, and usually higher than, the wavelength of the incident photons. If the target is a gas, Raman scattering may occur with a change in vibrational or rotational energy of the target molecules. Preferably, the disclosed embodiments utilize the vibrational Raman scattering effect.

In fluorescence, the interaction of incident light with molecular structures involves absorption of photons precisely matching the difference in energy levels of electrons in the target molecules. This interaction results in re-emission after a certain resonance lifetime. The results of fluorescence and Raman scattering are similar in that a photon with a frequency different from that of the incident photon is produced and the molecule is brought to a higher or lower energy level. The difference between the two methods is that the Raman effect may take place for any frequency of the incident light from light source 108. The Raman effect may not be considered a resonant effect. A fluorescent peak may be anchored to a specific frequency, but a Raman peak maintains a constant separation from the excitation frequency.

There may be two types of Raman scattering: Stokes and anti-Stokes. In Raman scattering, the effect detected by EPS system 100 relates to the absorption and subsequent emission that occurs through an intermediate quantum (vibrational state) of a material. No energy exchange may occur between the incident photons and the molecules. Thus, there is no Raman wavelength shift. Alternatively, energy exchanges may occur between the incident photons and the vibrational states of the molecules, which leads to Raman interaction. The energy differences are equal to the differences of the vibrational and rotational energy levels of the molecule.




~~~~


John Coates, Phd
Recipiant of the Coblentz Society's Williams-Wright Award

The Coblentz Society's Williams-Wright Award is presented annually to an industrial spectroscopist who has made significant contributions to vibrational spectroscopy while working in industry. The work may include infrared and/or Raman spectroscopy, instrumental development as well as theory, and applications of vibrational spectroscopy. Government labs are not considered industry in this definition. No restrictions are placed on the selection of the Awardee because of age, sex, or nationality, but the Awardee must still be working at the time the award is presented. The award consists of a frame certificate and an honorarium. In order to ensure that the award is based on an independent evaluation of the candidate’s achievements, the selection is made by a committee chosen by the Coblentz Society.


The Award is presented each year at the Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy. The Williams-Wright Award Symposium is held in honor of the awardee and immediately follows the presentation. In the picture to the right, John Coates was presented the 2013 Award with Shawn Mehrens (committee chair 2012-2013) and Jim Rydzak (Coblentz Society President 2013-2014).

The nomination should clearly state the significance of the contribution made by the nominee, e.g., the introduction of novel methods, techniques or theories; innovative work in the field of vibrational spectroscopy; significant improvement on existing methods, theory or techniques; or important impact on the field of vibrational spectroscopy arising from the volume of contributions in a specific area. The nomination packet should include a resume of the nominee's career including a publication list. Seconding letters to the nomination are useful, but not necessary. Files on nominees will be kept active for three years, after which the candidate must either be renominated with an updated file, or the file will be closed. Nominations should be sent to the Chair of the Williams-Wright Award Selection Committee. Nominations close May 1st for the 2016 award.




John Coates, Recipient of the Williams-Wright Award

CDEX had an employee that scammed them....I wonder who that was?

CDEX appoints John Coates as Technical Directorfor Spectroscopy Products

CDEX awarded spectroscopy patent 9,013,686 Inventors Brumfield, Poteet, Starzinger

CDEX spectroscopy tech: photoelectric detection processes include Raman scattering, fluorescence and spectral reflection. The EPS system uses all three processes to generate spectral data that is then combined to derive a target signature.




CDEX Director J. Coates, PhD 8 works in 18 publications in 1 language and 177 library holdings globally

http://ww.worldcat.org/identities/lccn-n84202639/


Roles: Author
Classifications: TP691, 665.5385
Publication Timeline
Most widely held works by John P Coates


Oils, lubricants, and petroleum products : characterization by infrared spectra ( Book )
2 editions published in 1985 in English and held by 98 WorldCat member libraries worldwide
Next-generation spectroscopic technologies 10-11 September 2007, Boston, Massachusetts, USA by Next-generation spectroscopi technologies( )
7 editions published in 2007 in English and held by 65 WorldCat member libraries worldwide
The redevelopment levy : a potential new source of municipal income by John P Coates( Book )
2 editions published between 1972 and 1973 in English and held by 5 WorldCat member libraries worldwide
Analytical methods for the characterisation of synthetic lubricants by John P Coates( )
2 editions published in 1987 in English and held by 3 WorldCat member libraries worldwide
Computerized infrared spectroscopy FT-IR and dispersive by Tomas Hirschfeld( Visual )
2 editions published in 1984 in English and held by 3 WorldCat member libraries worldwide
Summary: Describes some important methods and applications of computers in infrared spectroscopy
Next-Generation Spectroscopic Technologies ( )
1 edition published in 2007 in English and held by 2 WorldCat member libraries worldwide
Evaluation of Used Crankcase Oils Using Computerized Infrared Spectrometry. Appendices by Burwell B McCaa( Book )
1 edition published in 1984 in English and held by 1 WorldCat member library worldwide
This is the final report of a study to determine whether computerized infrared spectroscopy is a feasible technique for oil condition monitoring. The study addresses the major factors that influence the performance of a lubricant in service and demonstrates that these factors may be monitored with infrared spectroscopy. The study identifies specific regions and peaks within the infrared spectra to be monitored in a routine oil condition monitoring program and proposes abnormal threshold for quantitative measures of these regions and peaks. Evaluation criteria for five Army combat and tactical vehicle engines and one Air Force Administrative engine are developed. Further the study recommends a field test of the infrared methodology at a single Army installation. This document only includes computer printout with tables and plots
Computerized infrared spectroscopy. FT-IR and dispersive by Tomas Hirschfeld( Visual )
1 edition published in 1984 in English and held by 0 WorldCat member libraries worldwide
"The objectives of this program are to describe some important methods and applications of computers in infrared spectroscopy."

CDEX's Brumfield et al patent awarded in 2015 nbr 9,013,686 Inventors: poteet starzing brumfield seem to understand the detection of couterfiets and john coates phd can probably add plenty to move this along




The disclosed embodiments also may identify counterfeit pharmaceuticals and materials. These are materials put forth to match the group provided above, but, in fact, are not those materials. Counterfeit drugs are a rising problem, with placebos being substituted for the actual drugs. The disclosed embodiments also may be used to identify counterfeit perfumes, liquors, drinks, gasoline, industrial fluids, and the like. For the purposes of system 100, "real time" means results are available to an operator within 5 seconds of completion of the spectral scan performed by the instrument and subsequent storage of that spectrum. In order to be maximally useful for the medical, explosive detection, and counterfeit determination applications, real time results are essential. First responders also must have real time results, because time is of the essence of their activities during emergency situations. System 100 also may measure complex taggants in liquids and solids placed into the material for identification of counterfeits. Taggants with specific measurable properties, including, but not limited to, fluorescent materials added to a product, have been used for many years to differentiate a manufacturer's product from a counterfeit. Potential counterfeiters can duplicate the taggant and thus circumvent detection of their counterfeit product. System 100 has the capability of measuring complex molecules mixed with a product, making it extremely difficult (and thus not profitable) for a counterfeiter to duplicate that complex molecule. Counterfeits can thus be easily identified and separated from a legitimate product using the disclosed invention. A further unique feature of this invention is the variable integration scheme incorporated in the actual measurement of an unknown or known substance. The AWC spectrometer's integration time is set to a fixed period that prevents saturation of the AWC spectrometer's output spectrum for common materials to be measured. A baseline algorithm is applied that "flattens" the spectrum and stores the result. Another spectrum is obtained and summed with the first spectrum and this process is repeated until a pre-set property of the spectrum is reached. The integration process then is complete and the summed spectra with flattened baselines are stored as the beginning point for the signature database.

Some of this sure would take a spectro expert to fully understand and I bet Dr. John Coates can help get this past beta hospitals and into market!

CDEX's ValiMed mitigates diversion.

5-19-2015 admitted to diverting drugs from patients for his own use and said on other occasions he removed Dilaudid and Demerol from drug vials and replaced them with saline

The state attorney general's office filed charges Thursday afternoon




http://www.ellwoodcityledger.com

CDEX's ValiMed G4 = mitigation of diversion. Even LEGISLATION coming from diversion. Example, for stealing painkillers and replacing them with saline-filled syringes tainted with his blood




http://www.concordmonitor.com/news/work/business/13041503-95/legislation-sparked-by-hepatitis-c-outbreak-signed-into-law

CDEX's Dr J Stevenson counterfeit detection regarding "biosimilars"

Considerations for Formulary Inclusion of Biosimilars

Anti-counterfeit measures




preparing for the arrival of biosimilars in the United States - what the pharmacist needs to know

sept 2014

Activity Faculty James G. Stevenson, Pharm.D., FASHP Professor, Department of Clinical, Social, and Administrative Sciences University of Michigan College of Pharmacy Ann Arbor, Michigan President, Hospital and Health System Services Visante, Inc. James G. Stevenson, Pharm.D., FASHP, is Professor in the Department of Clinical, Social, and Administrative Sciences in the University of Michigan College of Pharmacy. He also serves as President, Hospital and Health System Services, for Visante, Inc. Dr. Stevenson received his Bachelor of Science and Doctor of Pharmacy degrees from Wayne State University in Detroit, Michigan. He then joined the faculty at the West Virginia University School of Pharmacy in Morgantown. He served as Director of Pharmaceutical Services at West Virginia University Hospitals. Subsequently he was named Director of Pharmacy Services at Detroit Receiving Hospital and University Health Center, Director of the Graduate Program in Health Systems Pharmacy Management in the Wayne State University College of Pharmacy, and Executive Director of Pharmacy Services for the Detroit Medical Center. He served for the past 15 years in the University of Michigan Hospitals and Health Centers, where he was Chief Pharmacy Officer. Dr. Stevenson received the American Society of Health-System Pharmacists (ASHP) Award for Distinguished Leadership in Health-System Pharmacy Practice in 2013. He is a Fellow of ASHP and has been recognized as Pharmacist of the Year by both the Michigan Society of Health-System Pharmacists and the Michigan Pharmacists Association. He has also been honored with the Distinguished Alumnus Award by the Wayne State University College of Pharmacy and the Joseph Oddis Leadership Award by the Michigan Society of Health- System Pharmacists. He completed a term of service on the ASHP Board of Directors and received the John W. Webb Lecture Award in 2010. In 2012, Dr. Stevenson was appointed to the Michigan Board of Pharmacy. Dr. Stevenson's major research interests include pharmacy practice management, pharmacoeconomics, pharmacy informatics, and medication safety.

http://ashpadvantagemedia.com/downloads/biosimupdate-handout-webinar.pdf

CDEX Inc. (CDEX) is a technology development company. The Company focuses chemical detection technologies to develop products in various markets including the healthcare, security and brand protection markets. The Company's Healthcare includes validation of medications, training and quality assurance; Security and Public Safety includes identification of substances of concern; and Brand Protection includes detection of counterfeit or sub-par products for brand protection. The Company is also exploring opportunities in select market verticals where its proprietary technology provide low cost/real time solutions to a growing concern such as conducting urine, blood and saliva analysis for detecting illegal drugs and performance enhancement substances. The Company continued development and enhancement of its ValiMed G4 system (VG4) for use in the pharmaceutical market and sales of its ID2 product for the security markets with its principal product lines.


http://topics.nytimes.com/top/news/business/companies/cdex-inc/index.html

CDEX identification of counterfeit drugs. SEC rpt 2014

Identification of substances of concern (e.g., explosives, illegal drugs and the detection of counterfeit drugs and medications to assist in the protection of the nation's drug supply)




http://www.secinfo.com/d1526c.n4C7.htm

Cdex's ValiMed G4 will be in demand! Already in demand as it is in beta testing.




Injectable drugs diverted at least 40 times in the last five years. Nurse was stealing patients' fentanyl, using the syringe on herself, then replacing it with saline for use on the patient "so cath lab patients were getting no sedation for their procedures,




http://www.healthleadersmedia.com/content/QUA-305497/10-Ways-to-Halt-Drug-Diversion

CDEX's NADDI Drug Diversion Detection Articles

http://www.businesswire.com/news/home/20050126005642/en/University-Utah-Health-Sciences-Center-Addresses-Narcotics#.VZadP_lViko

"ValiMed pretty much eliminates a major source of narcotic drug diversion," said Jim Jorgenson, Director of Pharmacy Services, and Associate Dean for Clinical Affairs, University of Utah College of Pharmacy. "Its spectral analysis ensures every returned syringe contains narcotics and not just water. The machine is the size of a shoebox and fits in our satellite pharmacy; any pharmacy technician can perform the validation in seconds."




Narcotic Accountability: Healthcare's Responsibility to Protect through Detection

http://www.naddi.org/aws/NADDI/pt/sd/calendar/38739/_PARENT/layout_details/false





Drug Diversion: How Robust is Your Prevention and Detection Program?

http://www.naddi.org/aws/NADDI/pt/sp/resources_publications




Recommendations about how third-party payers can take eff ective action on drug diversion, including its detection and prevention.

http://www.naddi.org/aws/NADDI/asset_manager/get_file/2739




The Challenges of Prescription Drug Abuse, Diversion and Counterfeiting for the Community, Law Enforcement and Industry - See more at: http://www.naddi.org/aws/NADDI/pt/sd/calendar/24683/_PARENT/layout_details/false#sthash.U19Ybn6o.dpuf




http://naddi.org/aws/NADDI/pt/sd/calendar/26177/_PARENT/layout_details/true

http://www.naddi.org/aws/NADDI/asset_manager/get_file/3143/drug_diversion_the_scope_of_the




Diversion felony Pharmacy detection

http://www.naddi.org/aws/NADDI/asset_manager/get_file/50875/in-ips_final_legislative_report.pdf

Lets GO CDEX!!

Diversion detection is much needed!!! Expert on hospital drug theft. The most egregious form of diversion worker will steal a syringe, shoot up, then replace the missing fentanyl or morphine with saline solution or water.




http://www.mlive.com/news/ann-arbor/index.ssf/2014/10/expert_theft_of_drugs_by_hospi.html

CDEX's VG4's diversion control capabilities are needed -




Addicts:

Empty a saline injection bottle. Go to a patient's room who's getting a Demerol infusion and remove the syringe. Inject Demerol into the empty saline bottle. Fill patient's syringe with an equivalent amount of saline.




http://www.newsleader

CDEX's ValiMed G4 will likely STOP horror stories like this -

A nurse admitted to taking patients' pain medications for herself and switching them out with salt water. she diverted hydromorphone, meperidine and morphine for her personal use and replaced the medication with normal saline.


The state investigation revealed that she had been switching out the drugs for more than five months before she was finally caught,

The Department of Public Health dealt with 15 cases of diversion of medications in 2014 on the part of nurses




http://www.wfsb.com/story/28006716/ct-nurse-on-probation-following-hospital-investigation

CDEX's.... Certainly seems the ValiMed G4 is needed!!




The remaining outbreaks involved personnel who tampered with syringes or vials containing fentanyl. This involved, for example, self-injecting fentanyl from a syringe, replacing the contents with a clear solution such as saline, and returning the syringe to the procedure area or anesthesia cart. In these 4 outbreaks, hepatitis C virus (HCV) infection was transmitted to at least 84 patients. In each of these 4 outbreaks, the implicated professional was HCV-infected and served as the source. Nearly 30,000 patients were potentially exposed to bloodborne pathogens and targeted for notification advising testing.




http://www.medscape.com/viewarticle/825801

CDEX:Diversion story March 2015. Looks like the CDEX G4 is needed. state police and DEA investigations.fentanyl removed from its ambulance drug boxes and replaced with morphine, a less potent painkiller




http://www.richmond.com/article

CDEX's G4 is needed. April 2015 stealing Fentanyl for personal use. She allegedly removed the drug from the manufacturer's containers and replaced it with water.

Civil lawsuit filed.




http://www.dailyindependent

CDEX's JG Stevenson is also President of Visante, which has a number of interesting alliances




http://www.pppmag.com/author/James_G_Stevenson

http://visanteinc.com/alliances/

http://visanteinc.com/consultants/james-stevenson-president-hospital-health-systems-services-visante-inc-and-visante-ltd/

CDEXs Stevenson a leading expert for oncology professionals, joins Memorial Sloan Kettering, U of Barcelona, U of of New England College of Pharmacy representatives regarding utilizing biosimilars for neutropenia safely and effectively.




2015

http://www.medscape.org/sites/townhall/public/biosimilar-matrix

CDEX's JG Stevenson PharmD, FASHP, will be speaking on preparing for biosimilars at 2015 Georgia Society of Health System Pharmacists

https://www.gshp.org/meetings.aspx?a=viewPost&PostID=28310

CDEX's Dr. Stevenson has known about enhanced photoemission spectroscopy (EPS) for years.



What is it worth to verify the contents of a drug vial or syringe? $20,000? $24,000? $100,000?


Drug Verification Becomes a Reality

By Gebhart, Fred


"Drug validation is an area I hope will develop," Stevenson said. "We use Valimed to check 10 high-risk meds compounded in our children's hospital and in our central IV clean room. But the device has some limitations."

One problem is a limited library of about 190 drugs and concentrations. …

"We found five compounding errors in the first 18 months, and we've found more errors since," he told Drug Topics

https://www.questia.com/magazine/1P3-2003310941/drug-verification-becomes-a-reality

CDEX's Coates: Instrumentation Design and Technology-Infrared Spectroscopy for Process Analytical Applications




http://media.johnwiley.com.au/product_data/excerpt/7X/04707220/047072207X-1.pdf

CDEX's JP Coates, PhD & DiMarco team - refers to development of several scientific instruments and analyzers in the areas of medical and clinical diagnostics, pharmaceutical and analytical testing




I have worked closely with the DiMarco team since the company was formed (nearly 10 yrs) for the development of several scientific instruments and analyzers in the areas of medical and clinical diagnostics, pharmaceutical and analytical testing. I've found them always easy to work with, continually willing to take up technical challenges, always concerned with delivering on-time, and available 24x7 for support.


DR. JOHN P. COATES

Coates Consulting, LLC




http://surgicaresoftware.com/

Amanita, thank you soooo much for the heads up on Cdex! I would never ever get it without ALL of your wonderful informative posts! What a treat it is to have such a person as you, posting so much! How do you find the time?

CDEX Dir reviews the history of infrared, near-infrared, and Raman spectroscopy for use as industrial QC or process control instruments, including the benefits and disadvantages of spectroscopy in these settings, and another article about Micro-ATR Infrared Spectroscopy

His expertise fits the ValiMed G4 technology nicely.

http://www.techexpo.com/toc/spctrs99.html

ARTICLES
•A Review of Current and New Technologies Used in Instrumentation for Industrial Vibrational Spectroscopy
John Coates
The author reviews the history of infrared, near-infrared, and Raman spectroscopy for use as industrial QC or process control instruments, including the benefits and disadvantages of spectroscopy in these settings.
•

•
•Visualization of Micro-ATR Infrared Spectroscopy
John P. Coates and John Reffner
The authors present an explanation of the principles along with a historical perspective of ATR and point out the areas in which it is most valuable.

CDEX's JP Coates, PhD CDEX Director: 2014 writes about tunable filters and tunable laser diodes, detectors, microspectrometer systems, UV, IR, in American Pharmaceutical Review. Gotta love the experience at Perkin Elmer combined with pharmaceutical knowledge and liquids.






MEMS fabrication is now used for infrared components, such as sources/emitters and detectors, and also for functional spectrometer components, including tunable Fabry-Perot (FP) filters and scanning Michelson interferometers. The latter example is discussed in more detail later as a fully functional micro FTIR spectrometer. MEMS sources and detectors are widely available for mid-infrared applications. The emitters may be pulsed to provide a mechanically free modulated IR output. Detectors, in the form of pyroelectric devices, are packaged as single, dual, and quad combinations, and also as linear arrays, nominally as 128, 256, and 512 packages. The big motivator behind the use of MEMS fabrication is that the devices are typically built from silicon, and in common with silicon computer chips, these devices are scaleable and the costs come down in volume. However, like computer chips, the upfront engineering costs are extremely high. Therefore, there needs to be a strong higher volume driver application to make such devices worthwhile. One MEMS-based application will be covered later. This application, which is driven by a high volume market, is the digital micro-mirror device (DMD), better known as the digital light projection (DLP) chip. In this case, the spectrometer is very much a secondary application, relative to volume usage.




Lasers and LEDs are a natural fit, size-wise, as efficient sources for microspectrometer systems. A wide range of tunable laser diodes (TDLs) are now available, primarily in the near-infrared spectral region, and broadly tunable mid-infrared lasers are available in the form of quantum cascade lasers (QCLs). In the broadly tunable format, these lasers essentially function as a spectrometer, where tuning ranges can be as broad as 2-3 microns wide. LEDs, while not tunable, may be obtained over a broad range of wavelengths covering from the UV (250nm) to the NIR (1450nm) and more recently out to the upper mid-IR (around 3 microns). The devices at the extremes (UV and the mid-IR) are more specialized and are expensive. However, LEDs with wavelengths from 360nm to 1450nm are relatively inexpensive and readily available, and can be packaged in multi-wavelength (multi-die) formats.




2014 American Pharmaceutical Review

A Review of New Small-Scale Technologies for Near Infrared Measurements

Posted: June 18, 2014




John Coates

Coates Consulting LLC




Dr. John Coates was educated and started his career in the UK. His first position was as an analytical chemist working for Castrol Oil Company. He graduated with the Royal Society of Chemistry (RSC) and obtained his Ph.D. in analytical chemistry at Brunel University with an initial focus on Raman Spectroscopy. Dr. Coates has 50 years of industrial experience. After moving to the USA as a Senior Staff Scientist at Perkin Elmer Corporation, Dr. Coates accepted positions at Spectra-Tech (Stamford, CT) and then at Nicolet Instruments (Madison, WI), and eventually returning to a position at PerkinElmer’s Real-Time Systems Division (Wilton, CT), a joint-venture with Dow Chemical Company (Midland, MI). In 1996 Dr. Coates opted to leave the corporate world and formed his own company, Coates Consulting LLC.

Since 1996 he has built Coates Consulting LLC, a network consultancy focused on applied and industrial instrumentation, optical spectroscopy, and analytical instruments and sensors for dedicated applications. His main focus for the company is on instrument miniaturization and spectral sensors. Dr. Coates has devised and developed more than 50 different instrument and sensor products for dedicated analyses and has worked with major corporations in major industry sectors; including pharma, environmental, industrial (chemical and consumer products), aerospace, computer technology, and medical. He was co-founder of two businesses for the development of products based on miniaturization: Sentelligence and microSpectral Sensors. In addition, Dr. Coates held Director positions at Global Technovations, Inc. (now On-Site Analysis, Inc.), a company that markets field-based oil analyzers, and MCEC (Measurement and Control Engineering Center) at the University of Tennessee.




http://www.americanpharmaceuticalreview.com/Featured-Articles/163573-A-Review-of-New-Small-Scale-Technologies-for-Near-Infrared-Measurements/

CDEX's tech director, Dr Coates, has been actively involved with this company's tech:

Spectral sensors can be configured to give discrete wavelength outputs for simple sensing to full range spectra in the form of a micro-spectral sensor for more complex applications.

http://www.sentelligence.com/core-technology/

Seems fitting that Dr. Coates literally wrote the book(s).

http://www.amazon.com/Approaches-Infrared-Spectroscopic-Practical-Spectroscopy/dp/1574447866

http://onlinelibrary.wiley.com/doi/10.1002/9780470988459.ch4/summary

https://books.google.com/books?id=OzAnX25h4soC&printsec=frontcover&dq=Applied+Spectroscopy:+A+Compact+Reference+for+Practitioners&hl=en&sa=X&ei=9wBWVb6uMoHHsAWa14GgBg&ved=0CCwQ6AEwAA#v=onepage&q=Applied%20Spectroscopy%3A%20A%20Compact%20Reference%20for%20Practitioners&f=false




http://www.sciencedirect.com/science/article/pii/B9780127640709500056




http://finance.yahoo.com/news/cdex-expands-technical-development-team-123000419.html




CDEX Expands Technical Development Team With Appointment of John Coates, Ph.D. as Technical Director for Spectroscopy Products

CDEX's ValiMed G4 uses multiple types of spectroscopy to analyse liquids.

CDEX's Dr. Coates is the inventor for this - Optical sensing device for fluid sensing and methods therefor

CDEX reports they have ongoing beta testing in multiple hospitals. Nice ta see their Technical Director for Spectroscopy Products (John Coates, PhD) has these successes.




Optical sensing device for fluid sensing and methods therefor
US 20140226149 A1


ABSTRACT


An optical spectral sensing device for determining at least one property of a fluid. The device has an elongated porous body, a first end and a second end, a solid-state optical emitter at the first end of the body oriented to emit radiation toward the second end of the body, and a solid-state optical detector at the second end of the body oriented to detect radiation emitted by the optical emitter. A package for detecting properties of a fluid includes a body defining a cavity, with a movable and biased carrier for an optical detector or emitter mounted in the cavity for increased reliability. A system for determining relative concentrations of fluids in a sample includes emitter/detector pairs operating at reference wavelength and wavelengths corresponding to absorption peaks of at least two fluids, and a processor for determining concentration based on measured data and calibration data.


Publication number US20140226149 A1
Publication type Application
Application number US 14/124,601
PCT number PCT/US2012/041431
Publication date Aug 14, 2014
Filing date Jun 7, 2012
Priority date Jun 7, 2011
Also published as CN103748441A, EP2718680A1, EP2718680A4, WO2012170743A1
Inventors John Coates, Robert Qualls
Original Assignee John Coates, Robert Qualls
Export Citation BiBTeX, EndNote,

CDEX NEWS 8K ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT!

http://www.sec.gov/Archives/edgar/data/1173738/000121465915004406/j5291508k.htm

CDEX's Dr. Coates will likely help make CDEX a big success. Inventors John Coates Integrated sensing module for handheld spectral measurements




http://www.google.com/patents/US7907282





Integrated sensing module for handheld spectral measurements
US 7907282 B2


ABSTRACT


An integrated spectral sensing engine featuring energy sources and detectors within a single package includes sample interfacing optics and acquisition and processing electronics. The miniaturized sensor is optimized for specific laboratory and field-based measurements by integration into a handheld format. Design and fabrication components support high volume manufacturing. Spectral selectivity is provided by either continuous variable optical filters or filter matrix devices. The sensor's response covers the range from 200 nm to 25 µm based on various solid-state detectors. The wavelength range can be extended by the use of filter-matrix devices. Measurement modes include transmittance/absorbance, turbidity (light scattering) and fluorescence (emission). On board data processing includes raw data acquisition, data massaging and the output of computed results. Sensor applications include water and environmental, food and beverage, chemical and petroleum, and medical analyses. These can be expanded into various field and consumer-based applications.


Publication number US7907282 B2
Publication type Grant
Application number US 12/136,219
Publication date Mar 15, 2011
Filing date Jun 10, 2008
Priority date Aug 14, 2003
Fee status Paid
Also published as US7459713, US20070084990, US20080265146
Inventors John Coates
Original Assignee Microptix Technologies, Llc
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (107), Non-Patent Citations (8), Referenced by (2), Classifications (33), Legal Events (5)
External Links: USPTO, USPTO

I suggest you go to the SEC? Here is the link! Let the CDEX board know what happened!

http://www.sec.gov/

Whistleblower Information - submit a tip. Reward?